Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

Cellerant awarded BARDA contract to develop ARS treatment

Sep. 2, 2010

ImmuneRegen to submit proposal for funding Homspera development

Sep. 1, 2010

FDA approves Suboxone sublingual film

Sep. 1, 2010

BTG to receive marketing rights for Nycomed's CroFab and DigiFab

Sep. 1, 2010

Escitalopram prevents relapse in patients with alcoholism and comorbid affective disorders

Aug. 31, 2010

Risperidone may have the potential to treat alcohol dependence

Aug. 30, 2010

NIH renews research funding for Homspera in radiation-induced lung injury

Aug. 27, 2010

Aoxing receives approval in China for buprenorphine/naloxone clinical trial

Aug. 26, 2010

Bolder BioTech receives grant to study IL-11 analogue for acute radiation syndrome

Aug. 23, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...